Literature DB >> 10572290

Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report.

E M Martin1, D L Pitrak, R M Novak, K J Pursell, K M Mullane.   

Abstract

We evaluated subclinical mental and motor slowing in 142 HIV-seropositive patients without dementia, using computerized simple and choice reaction time tasks and self-report measures of psychological distress. Patients on antiretroviral therapy at the time of testing (n = 79) had significantly faster choice reaction times (p < 0.05), indicating faster mental processing speed, than untreated patients (n = 63). These faster RTs could not be attributed to differences in age, education, risk factors, degree of immunosuppression, substance abuse history, peripheral neuropathy, or psychological distress. Reaction time tasks should be investigated further as potential outcome measures in clinical trials, particularly for subjects with few or no overt cognitive deficits.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10572290     DOI: 10.1076/jcen.21.5.730.867

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  10 in total

1.  Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.

Authors:  Mark L Ettenhofer; Jessica Foley; Steven A Castellon; Charles H Hinkin
Journal:  Neurology       Date:  2010-03-10       Impact factor: 9.910

2.  Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

Authors:  C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

3.  Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.

Authors:  Diana L Sylvestre; Jennifer M Loftis; Peter Hauser; Sander Genser; Helen Cesari; Nicolette Borek; Thomas F Kresina; Leonard Seeff; Henry Francis
Journal:  J Urban Health       Date:  2004-12       Impact factor: 3.671

4.  Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection.

Authors:  Ofilio Vigil; Carolina Posada; Steven Paul Woods; J Hampton Atkinson; Robert K Heaton; William Perry; Tarek I Hassanein; Igor Grant; Scott L Letendre
Journal:  J Clin Exp Neuropsychol       Date:  2008-03-04       Impact factor: 2.475

Review 5.  Functional consequences of HIV-associated neuropsychological impairment.

Authors:  Ashley A Gorman; Jessica M Foley; Mark L Ettenhofer; Charles H Hinkin; Wilfred G van Gorp
Journal:  Neuropsychol Rev       Date:  2009-05-27       Impact factor: 7.444

6.  Aging, neurocognition, and medication adherence in HIV infection.

Authors:  Mark L Ettenhofer; Charles H Hinkin; Steven A Castellon; Ramani Durvasula; Jodi Ullman; Mona Lam; Hector Myers; Matthew J Wright; Jessica Foley
Journal:  Am J Geriatr Psychiatry       Date:  2009-04       Impact factor: 4.105

Review 7.  Behavioral and Physical Activity Interventions for HAND.

Authors:  Jessica L Montoya; Brook Henry; David J Moore
Journal:  Curr Top Behav Neurosci       Date:  2021

8.  Neural response to working memory demand predicts neurocognitive deficits in HIV.

Authors:  Ronald A Cohen; S Siegel; J M Gullett; E Porges; A J Woods; H Huang; Y Zhu; K Tashima; M-Z Ding
Journal:  J Neurovirol       Date:  2017-12-26       Impact factor: 3.739

Review 9.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

10.  Neurocognitive performance differences between black and white individuals with HIV disease are mediated by health literacy.

Authors:  Ilex Beltran-Najera; Jennifer L Thompson; Anastasia Matchanova; Kelli L Sullivan; Michelle A Babicz; Steven Paul Woods
Journal:  Clin Neuropsychol       Date:  2021-07-26       Impact factor: 3.535

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.